SuzanneLepage's profile picture. Bridging the group benefits and pharmaceutical industries

Suzanne Lepage

@SuzanneLepage

Bridging the group benefits and pharmaceutical industries

Joined March 2009
Similar User
GreenShieldCo's profile picture. GreenShield is an integrated health and benefits organization championing Better Health for All.

@GreenShieldCo

BenCanMag's profile picture. Benefits Canada Magazine. Required reading for pension, benefits and investment executives. Sign up for our daily newsletter: https://t.co/j56Fx4dHDL

@BenCanMag

MorseConsult's profile picture. Deciphering pharmaceutical
market access signals to create reimbursement success.

@MorseConsult

PMPRB_CEPMB's profile picture. Patented Medicine Prices Review Board | Conseil d'examen du prix des médicaments brevetés. Twitter Protocol/protocole relatif à Twitter: https://t.co/DqDAR517dj

@PMPRB_CEPMB

BinderLouise's profile picture. Co-Chair of @_CONECTed and Patient Health Policy Consultant for @saveyourskinfdn / @sauvetapeau

@BinderLouise

CLHIA's profile picture. The Canadian Life and Health Insurance Association represents Canada's life and health insurers. Follow @ACCAP_QC for tweets in French.

@CLHIA

LongwoodsNotes's profile picture. Better Care | Health Services Publishing, Education and Recruitment

@LongwoodsNotes

bbdcanada's profile picture. We’re in the business of helping working Canadians. 🇨🇦 Talk to us about #employeebenefits and #insurance to see how we can help your #workplace.

@bbdcanada

jackieportercfp's profile picture. Canada’s Financial Confidante. Building Your Fortune and Financial IQ. One conversation at a time. Co Author Single by Choice or Chance. The smart woman’s guide

@jackieportercfp

BMC_Patients's profile picture. The Best Medicines Coalition is a national alliance of 31 Canadian patient organizations.

@BMC_Patients

KristinaGentes's profile picture. Kinda Reluctant Hockey Mom I Passionate about Health & Innovation I Political Junkie. | All Views are mine only.

@KristinaGentes

gw_wyatthealth's profile picture. Concerned Canadian. Patients matter. Tweets are my own.

@gw_wyatthealth

How plan sponsors, insurers are considering coverage of weight-loss drugs amid rising use of Ozempic via @BenCanMag lnkd.in/gH4-W_Uj


At @BenCanMag Canadian Leadership Council on Drug Plan Partnerships we brought together plan advisors to discuss innovation in drug development and its impact on Canadian private drug plans. Would love to hear your thoughts. benefitscanada.com/microsite/bene…


The Plan Sponsor's Guide to Rare Diseases addresses many of the issues that impact Canadian private plans. I learned a lot by working on this and hope you do too. benefitscanada.com/microsite/the-… via @BenCanMag #RareDisease #benefits


Honoured to author the private payer section of @IQVIA Canada PharmaFocus report again this year. (Subscription Required)

SuzanneLepage's tweet image. Honoured to author the private payer section of @IQVIA Canada PharmaFocus report again this year. (Subscription Required)

Suzanne Lepage Reposted

At Express Scripts Canada, we're tracking medications and technologies that improves the health of Canadians. If you'd like an in-depth view, download your copy of our 2022 Drug Trend Report here: bit.ly/37kd4N2 #HR #PBM #Benefits #TPA

ExpressRxCanada's tweet image. At Express Scripts Canada, we're tracking medications and technologies that improves the health of Canadians. If you'd like an in-depth view, download your copy of our 2022 Drug Trend Report here: bit.ly/37kd4N2 

#HR #PBM #Benefits #TPA

Catch up on @BenCanMag Chronic Disease at Work conference coverage benefitscanada.com/microsite/chro…


Catch up on the coverage from @BenCanMag 2021 Face to Face in Drug Plan Management Forum benefitscanada.com/benefits/healt…


Gene therapies could reshape the way genetic diseases are managed because they target the underlying cause of genetic disease rather than just treating complex medical conditions. I learned a lot writing this for @BenCanMag and I hope you do to. online.fliphtml5.com/fuinl/ikrd/#p=…


My article in the November 2021 issue of IQVIA PRA includes profiles of several Canadian private payers to help PRA subscribers improve partnerships, submissions and ongoing collaborations. @IQVIA

SuzanneLepage's tweet image. My article in the November 2021 issue of IQVIA PRA includes profiles of several Canadian private payers to help PRA subscribers improve partnerships, submissions and ongoing collaborations. @IQVIA

PGx testing may be included in employee benefits plans; however, there is significant variability between providers and tests. This guide gives practical guidance on selecting a provider. I learned a lot working on this project, and I hope you do too. ow.ly/ZMFN50GUuyg


The PLAN SPONSORS GUIDE TO DIABETES provides education and resources on how to support plan members living with diabetes or caregivers of people with diabetes. I learned so much writing this guide, and I hope you do too! benefitscanada.com/microsite/bene…


Suzanne Lepage Reposted

@SuzanneLepage & Lindy Forte provide thoughtful insight into the importance of transparency in the Private Payer's HTA process at today's #CADTHSymp breakfast session.


.@IQVIA Canada PRA Subscribers check out the August 2021 issue for my article on @GSC_1957 Green Shield Canada's Biosimilar Transition Program.

SuzanneLepage's tweet image. .@IQVIA Canada PRA Subscribers  check out the August 2021 issue for my article on @GSC_1957 Green Shield Canada's Biosimilar Transition Program.
SuzanneLepage's tweet image. .@IQVIA Canada PRA Subscribers  check out the August 2021 issue for my article on @GSC_1957 Green Shield Canada's Biosimilar Transition Program.

.@BenCanMag 2021 CLC on Drug Plan Partnerships examined the evolution of health economics & formulary decision-making in Canadian private drug plans. Managed formularies help manage drug plan costs, but also present potential financial & legal risks benefitscanada.com/microsite/bene…


IQVIA Canada PRA subscribers – check out the May 2021 issue for 2 articles I co-authored: (1) BC - Private and Public Payer Integration (with Brad Millson and Tommy Lan) (2) Breaking Down the Facts About Private Drug Plan Costs (with @jfarago1)

SuzanneLepage's tweet image. IQVIA Canada PRA subscribers – check out the May 2021 issue for 2 articles I co-authored:

(1) BC - Private and Public Payer Integration (with Brad Millson and Tommy Lan)

(2) Breaking Down the Facts About Private Drug Plan Costs  (with @jfarago1)

Suzanne Lepage Reposted

A great read from @BenCanMag that speaks to the need for specialty drug prior authorization – when prior authorization is delayed or declined, plan members' conditions can worsen. Learn more 👉 bit.ly/38OxiNo

TELUSHealth's tweet image. A great read from @BenCanMag that speaks to the need for specialty drug prior authorization – when prior authorization is delayed or declined, plan members' conditions can worsen. Learn more 👉 bit.ly/38OxiNo

Suzanne Lepage Reposted

The private-payer perspective matters when assessing the value of a medication – and pharmacoeconomic analysis can be a tool in the private-payer decision making process. Learn more from the @BenCanMag 2020 Face to Face Drug Plan Management Forum. 👉 bit.ly/3bTxEE9

TELUSHealth's tweet image. The private-payer perspective matters when assessing the value of a medication – and pharmacoeconomic analysis can be a tool in the private-payer decision making process. Learn more from the @BenCanMag 2020 Face to Face Drug Plan Management Forum. 👉 bit.ly/3bTxEE9

Ensure you understand your prior authorization program to manage potential risks: ow.ly/tTvg50Dcpvo via @BenCanMag


How does your drug plan compare? Read the IMC Analysis of Private Drug Claim Cost Drivers (2016–2019) ow.ly/yt4B50Dbxs1

SuzanneLepage's tweet image. How does your drug plan compare? Read the IMC Analysis of Private Drug Claim Cost Drivers (2016–2019)  ow.ly/yt4B50Dbxs1

Suzanne Lepage Reposted

Such a wise statement. #BidenHarris2020 #pandemic

I see the election as a triumph of science over anti-science. Our nation is built on the backs of our great research universities that allowed us to achieve victory in WWII, go to the moon, defeat USSR in Cold War, treat HIV/AIDS. When POTUS tried to slaughter science he was done



Loading...

Something went wrong.


Something went wrong.